StudyFinder

HEALEY ALS Platform Trial

Status: Recruiting

The HEALEY ALS Platform Trial is a research trial that tests the safety and effectiveness of multiple treatments in ALS. A regimen is a specific course of treatment, each with a different study drug. We are doing this research to find out if different treatments have an effect on Amyotrophic Lateral Sclerosis (ALS). We also want to find out if these treatments are safe to take without causing too many side effects.

I'm interested

Sex: Male or Female
Age Group: 18 years and over
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• 18 years or older
• diagnosed with sporadic or familial ALS
• weakness started no more than 36 months ago -able to to swallow pills and liquids
Exclusion Criteria:

• unstable medical or mental health condition
• limitations on prior or current use of certain medications (study staff will review)
• women who are pregnant or breast feeding
Interventions:

Drug: ABBV-CLS-7262, Drug: DNL343

Conditions:

Rare Diseases, Brain & Nervous System

Keywords:

Clinics and Surgery Center (CSC), ALS, amyotrophic lateral sclerosis

Study Contact: Valerie Ferment - ferm0016@umn.edu
Principal Investigator: David Walk
Phase: PHASE2
IRB Number: SITE00000881
See this study on ClinicalTrials.gov

Back